Rainbow Childrens Medicare Ltd.
RAINBOW · NSE · Healthcare
With a 20% margin of safety, our buy-below price is ₹669.42.
Piotroski F-score 4/9 — quality of earnings & balance sheet.
Investability checklist
- ✓ROE above 15%17.9%
- ✕Low debt (D/E < 0.5)0.54x
- ✓Positive free cash flow
- ✓Revenue growth > 10%24%
- ✓Earnings growing39%
- ✓Net margin ≥ 10%16.3%
- ✓Current ratio > 1.53.59
- ✕Below our fair value
- ✕Margin of safety ≥ 20%
- ✓Above 200-day average
- ✓Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 9.07
- ✕Piotroski ≥ 74/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Strengths
- •Healthy profit margin (16.3%).
- •Financially solid — Altman Z 9.07.
Opportunities
- •Earnings growing (39% YoY).
- •Revenue growing (24% YoY).
Threats
- •Trades ~41% above our estimated fair value.
About Rainbow Childrens Medicare Ltd.
Rainbow Children's Medicare Limited operates a multi-specialty paediatric, obstetrics, and gynaecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children's Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation
More in Healthcare
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.